查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829051

诊断影像设备市场（按产品类型、便携性、应用和最终用户划分）—2025-2032 年全球预测

Diagnostic Imaging Equipment Market by Product Type, Portability, Application, End-User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，诊断影像设备市场将成长至 717.7 亿美元，复合年增长率为 6.09%。

主要市场统计数据
基准年2024年 447亿美元
预计2025年 472.7亿美元
预测年份：2032年 717.7亿美元
复合年增长率（%） 6.09%

关于技术创新、临床需求变化和业务需要如何改变诊断影像设备的采用和使用的权威概述

诊断影像仍然是现代临床决策的支柱，它能够在许多专业领域实现更早的发现、更准确的诊断和更完善的治疗监测。虽然电脑断层扫描、磁振造影造影、核子医学影像、超音波和X射线等影像方式仍然是治疗途径中不可或缺的，但不断发展的临床指南和技术进步正在日益影响着采购和使用模式。相关人员必须在复杂的环境中探索，必须在临床有效性、病人安全、成本控制和工作流程优化之间取得平衡，才能创造可衡量的价值。

人口结构变化和慢性病的增加正在重新定义临床需求，导致影像处理量不断增加，并重新强调吞吐量和效率。同时，从硬体小型化到软体驱动的影像增强等技术创新正在改变设备投资的价值提案。因此，医疗保健提供者和供应商不仅要考虑资本成本，还要考虑生命週期服务模式、与电子健康记录的整合以及支援多学科护理的能力。有鑑于此，企业主管和临床领导者需要清晰、基于证据地了解特定模式的进展、不断变化的监管环境以及报销压力将如何影响他们未来的筹资策略和营运重点。

人工智慧、即时诊断模式、混合成像趋势以及基于价值的指令将如何从根本上改变诊断成像格局

技术、临床和经济因素正在彻底改变诊断影像领域。人工智慧和先进的影像分析技术实现了自动分诊、增强的病变检测和定量生物标记，从而加快了诊断速度并提高了可重复性。同时，混合影像和多模态整合技术正在透过结合解剖和功能数据来提高临床特异性，从而改变肿瘤学和神经病学的诊断演算法。

同时，以患者为中心的医疗服务模式正在缩小集中式放射科的规模，并推广可携式和床边成像解决方案，使诊断能力更贴近床边和社区环境。基于价值的报销模式也在重塑采购和服务协议，供应商更重视可证明的疗效、吞吐量和总拥有成本，而不仅仅是购置价格。最后，对辐射剂量优化、环境永续性和人体工学设计的日益关注正在影响产品开发和采购标准。因此，那些将产品蓝图与软体主导的工作流程、互通性标准和灵活的商业模式相结合的公司，最有可能利用这些转型变革。

评估近期关税变化如何改变整个诊断影像设备价值链的供应链、采购决策和製造策略

美国将于2025年加征关税，这为全球诊断影像设备供应链和筹资策略带来了新的复杂性。依赖跨境采购精密零件和半导体相关子系统的製造商面临着不断上升的投入成本和更长的前置作业时间，这迫使他们迅速重新评估供应商集中度风险。为此，许多公司加快了供应商多元化的步伐，在近岸生产关键次组件，并重新设计产品，以减少对受关税影响零件的依赖。

由于成本压力通常会透过供应链传递，医疗保健提供者和设备经销商不得不重新协商采购条款和服务合约。资本投资委员会对总生命週期成本的影响以及短期资本支出与长期服务承诺之间的平衡变得更加敏感。同时，一些供应商寻求垂直整合和策略伙伴关係，以确保关键投入并稳定价格。监理合规和与关税相关的行政负担也随之增加，凸显了贸易专业知识在采购和合约签订中的重要性。整体而言，关税环境已成为供应链韧性倡议、供应商关係重组和製造在地化策略加速推进的催化剂。

以细分为主导，对最终使用者采购行为提供独特的观点，影响模式差异化、可携性权衡、临床应用优先顺序和策略定位

从产品类型、便携性、应用和最终用户维度解读细分洞察，可以明确临床需求和机会的交会点。按产品类型，电脑断层扫描器不断发展，分为高切片、中切和低切片影像，用途从进阶截面血管检查到常规紧急诊断。磁振造影分为针对高场强优化的封闭式系统和优先考虑患者舒适度和介入路径的开放系统。核子造影分为 PET 和 SPECT，PET 在分子肿瘤学方面保持优势，SPECT 则适用于更广泛的心臟病学和功能性影像适应症。超音波具有广泛的临床效用，包括用于一般诊断的 2D 影像、推进产科和胎儿可视化的 3D 和 4D 平台以及增强血管和心臟血流评估的多普勒系统。 X 光系统继续从类比平台过渡到数位射线，改善成像工作流程并与 PACS 和报告系统整合。

便携性定义了另一个差异化维度：固定影像设备支援高通量集中式服务，而可携式影像设备（从手持式到便携式设备）则支援在紧急情况和偏远地区进行分散式诊断和快速回应。应用主导的细分揭示了与临床领域相符的影像设备采用：循环系统利用冠状动脉和血管成像进行干预计划和随访；神经病学应用脑部和脊髓成像进行中风和退化性疾病管理；妇产科强调胎儿监护和盆腔成像；肿瘤科需要早期发现和分期以及持续监测；整形外科依赖于骨折检测和以关节为中心的检查。终端使用者细分同样影响采购订单和服务期望：门诊医疗中心优先考虑经济高效、快速週转的系统；影像中心强调专业的通量和影像设备组合；医院和诊所寻求能够处理各种急性和择期手术的多功能整合平台。模式的选择和配置直接影响临床工作流程、人员配备和下游产生收入，因此了解这些部分的交集对于产品定位、资本规划和临床参与策略至关重要。

区域医疗保健基础设施、监管分散和投资重点如何推动全球市场采用和商业策略的差异

区域动态对诊断成像产业的采用曲线、监管方法和创新传播有重大影响。在美洲，完善的医疗基础设施、整合的供应商布局以及先进的报销框架，支援高端医疗设备和整合软体解决方案的快速普及。在欧洲、中东和非洲，监管碎片化和报销环境的差异化导致了市场采用的不均衡趋势：已开发国家更青睐先进的治疗方法和高端设备，而其他市场则更青睐经济高效、性能强大的解决方案。在某些地区，政策转变和集中采购进一步影响了定价和竞标行为。在亚太地区，医疗基础设施投资、不断增长的临床需求以及有利的公共卫生倡议正在加速高端医疗设备和可携式成像解决方案的普及，其中一些市场尤其热衷于本地製造伙伴关係和增值服务。

区域供应链、临床培训的可近性以及患者的人口结构差异都会影响设备生命週期、服务模式和售后支援的结构。因此，跨区域运营的供应商和提供者必须根据当地的报销情况和基础设施限制，以客製化产品系列、资金筹措方案和临床教育计画。策略性的区域伙伴关係和灵活的上市模式对于将全球创新转化为永续的本地应用，并降低监管变化和贸易中断的风险至关重要。

深入分析现有企业、敏捷创新者和软体颠覆者如何透过伙伴关係、服务和模组化产品策略来塑造竞争动态

诊断影像领域的竞争格局主要体现在：成熟的跨国製造商、利基市场创新者，以及越来越多专注于分析和工作流程优化的软体参与企业。现有的设备製造商持续强调整合的软硬体捆绑、生命週期服务协议以及融资解决方案，以减少大型供应商的实施阻力。同时，规模较小的公司和新兴企业公司则凭藉专注的临床应用、颠覆性的外形规格（例如掌上超音波）以及可部署为云端服务的先进影像处理演算法，在竞争中脱颖而出。

策略伙伴关係、共同开发契约和定向收购已成为规模化和创新的主要槓桿。许多公司正在投资模组化架构，以实现功能增量升级，延长产品寿命，并透过软体订阅和临床决策支援工具产生经常性收益。售后服务和设备託管计画作为收入稳定的产品，正日益受到青睐，这些产品能够将供应商的奖励与提供者的执行时间和绩效挂钩。在竞争日益激烈的环境中，市场领导正在平衡资本密集型研发与临床检验、培训计画和客户成功团队的上市时间承诺，以加速采用并获得下游业务收益。

供应商和提供者应采取切实可行的优先策略行动，以创新、降低供应链风险，并使商业模式与临床结果保持一致

产业领导者应采取多管齐下的策略，在创新与供应链韧性以及以客户为中心的商业模式之间取得平衡。优先投资软体和分析技术可以创造差异化的临床价值，同时透过订阅服务实现经常性收益。同时，多元化供应商基础并评估近岸外包和区域製造伙伴关係可以降低贸易中断和投入成本波动带来的风险。领导者还应重新思考传统的销售方式，提供可配置的资金筹措、绩效挂钩合约以及全面的託管服务包，将奖励与提供者的绩效目标相结合。

在营运方面，建立强大的临床检验计划和以临床医生为中心的培训可以加速技术应用并建立长期忠诚度。供应商团队应投资于互通性和开放式架构设计，以简化与异质医院生态系统的集成，并支援多供应商工作流程。最后，随着采购委员会越来越重视环境和病人安全，公司必须将永续性和剂量优化功能纳入其产品蓝图。透过将技术创新与灵活的商业模式和弹性营运相结合，产业领导者可以实现策略成长，同时为客户提供可衡量的临床和财务价值。

结合相关人员访谈、临床文献分析和情境检验的稳健混合方法研究途径可确保获得可靠且可操作的见解

这些见解背后的调查方法融合了定性和定量的严谨性，并采用结构化方法，旨在对证据进行三角检验并确保可复製性。主要研究包括对临床医生、采购负责人、生物医学工程师和行业高管的结构化访谈，提供有关医疗设备使用、维护週期和采购决策标准的第一线观点。次要研究包括同行评审的临床研究、监管指导文件、製造商技术规范和公开的财务信息，以评估技术准备、临床效用和运营限制。

数据合成采用交叉验证技术来协调差异并识别共识趋势。案例研究和实际实施情况的分析，总结了关于采用障碍和成功因素的经验教训。调查方法还结合了情境分析，以在不同监管和供应链条件下对策略假设进行压力测试。研究发现，存在一些局限性，例如区域报销实践的差异以及软体主导创新的动态性，并透过持续的相关人员参与和迭代检验週期来应对这些局限性，以保持研究的相关性和准确性。

简明综合了决定诊断影像领域竞争成功和临床影响的技术、商业和政策因素

总体而言，诊断影像产业正处于曲折点，技术进步、医疗服务模式的转变以及供应链现状正在共同重新定义价值创造。软体、影像分析和携带式硬体领域的创新正在释放新的临床用例，并支援分散式护理工作流程，而筹资策略也越来越多地以总体拥有成本、与临床结果的关联性以及服务的连续性为导向。贸易政策和关税的变化凸显了供应链多元化的重要性，加速了与区域製造业的对话，并为采购和产品设计决策增添了策略层面。

成功将产品创新与弹性运作、灵活的商业性框架和以临床医生为中心的实施计划相结合的组织将获得竞争优势。此外，检验临床效果、确保跨司法管辖区的法规合规性以及提供可靠的售后服务的能力将决定长期的供应商-提供者关係。随着该领域的不断发展，相关人员应保持敏捷的投资组合规划，并优先考虑能够在不同医疗环境中带来显着临床效益和营运效率的投资。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 将人工智慧驱动的影像分析软体整合到诊断成像工作流程中，以提高准确性和效率
  • 快速采用光子计数 CT 扫描仪来提高空间解析度并减少辐射剂量
  • 开发可携式和手持式超音波设备，实现远端地点的照护现场诊断
  • 混合 PET/MRI 系统在肿瘤学中越来越多地用于同时代谢和结构成像
  • 透过安全的资料共用和人工智慧诊断支援工具扩展云端基础的PACS 解决方案

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第 8 章：诊断影像设备市场（依产品类型）

  • 电脑断层扫描（CT）扫描仪
    • 高切CT扫描仪
    • 低切片CT扫描仪
    • 中切CT扫描仪
  • 磁振造影（MRI）设备
    • 封闭式MRI系统
    • 开放式磁振造影系统
  • 核子造影设备
    • PET系统
    • SPECT 系统
  • 超音波系统
    • 二维超音波系统
    • 3D和4D超音波系统
    • 多普勒超音波系统
  • X射线系统
    • 模拟X射线系统
    • 数位X射线系统

第 9 章：诊断影像设备市场（按便携性）

  • 固定成像设备
  • 可携式成像设备
    • 手持行动装置
    • 可运输设备

第 10 章：诊断影像设备市场（按应用）

  • 心臟病学
    • 冠状动脉成像
    • 血管影像
  • 神经病学
    • 脑部扫描
    • 脊髓影像检查
  • 妇产科
    • 胎儿监护
    • 骨盆腔影像检查
  • 肿瘤学
    • 早期检测
    • 分期和监控
  • 整形外科
    • 骨折检测
    • 联合考试

第 11 章：诊断影像设备市场（按最终用户）

  • 门诊治疗中心
  • 诊断影像中心
  • 医院和诊所

第 12 章：按地区分類的诊断影像设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 13 章：诊断影像设备市场（按类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国诊断影像设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Agfa-Gevaert Group
    • Analogic Corporation
    • Avonix Imaging, LLC by Nikon Corporation
    • Barco NV
    • Bracco SpA
    • Canon Medical Systems Corporation
    • Carestream Health, Inc.
    • Esaote SpA
    • FUJIFILM Holdings Corporation
    • GE HealthCare Technologies Inc.
    • Hologic, Inc.
    • Konica Minolta, Inc.
    • Koninklijke Philips NV
    • Medtronic PLC
    • MinFound Medical Systems Co., Ltd.
    • Neusoft Corporation
    • Planmed Oy
    • Samsung Electronics Co., Ltd
    • Shanghai United Imaging Healthcare Co., Ltd.
    • Shenzhen Mindray Bio-Medical Electronics Co Ltd
    • Shenzhen SONTU Medical Imaging Equipment Co., Ltd.
    • Shimadzu Corporation
    • Siemens Healthineers
    • Stryker Corporation
    • Ziehm Imaging GmbH
Product Code: MRR-43676CF420BD

The Diagnostic Imaging Equipment Market is projected to grow by USD 71.77 billion at a CAGR of 6.09% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 44.70 billion
Estimated Year [2025] USD 47.27 billion
Forecast Year [2032] USD 71.77 billion
CAGR (%) 6.09%

An authoritative overview of how technological innovation, clinical demand shifts, and operational imperatives are reshaping diagnostic imaging equipment adoption and use

Diagnostic imaging equipment continues to serve as the backbone of modern clinical decision-making, enabling earlier detection, more accurate diagnoses, and better treatment monitoring across a broad range of specialties. Imaging modalities such as computed tomography, magnetic resonance imaging, nuclear imaging, ultrasound, and X-ray remain integral to care pathways, while evolving clinical guidelines and technological advances are increasingly shaping procurement and utilization patterns. Stakeholders are navigating a complex environment where clinical efficacy, patient safety, cost containment, and workflow optimization must be balanced to deliver measurable value.

Clinical demands are being redefined by a confluence of demographic shifts and rising chronic disease prevalence, which together increase imaging volumes and place renewed emphasis on throughput and efficiency. At the same time, technological innovations-ranging from hardware miniaturization to software-driven image enhancement-are altering the value proposition of equipment investments. Providers and vendors must therefore consider not only capital cost but also lifecycle service models, integration with electronic health records, and the ability to support multidisciplinary care. Given this landscape, executives and clinical leaders need a clear, evidence-based picture of how modality-specific advances, regulatory changes, and reimbursement pressures will influence procurement strategies and operational priorities going forward.

How artificial intelligence, point-of-care modalities, hybrid imaging trends, and value-based imperatives are fundamentally altering the diagnostic imaging landscape

The diagnostic imaging landscape is undergoing fundamental transformation driven by converging technological, clinical, and economic forces. Artificial intelligence and advanced image analytics are enabling automated triage, enhanced lesion detection, and quantitative biomarkers that can accelerate diagnosis while improving reproducibility. Concurrently, hybrid imaging and multimodal integration are increasing clinical specificity by combining anatomical and functional data, which is transforming diagnostic algorithms in oncology and neurology.

Meanwhile, the push toward patient-centric care is promoting portable and point-of-care imaging solutions that decongest centralized radiology suites and bring diagnostic capability closer to bedside and community settings. Value-based reimbursement models are also reshaping purchase and service contracts, with providers placing greater emphasis on demonstrable outcomes, throughput, and total cost of ownership rather than acquisition price alone. Lastly, an increased focus on radiation dose optimization, environmental sustainability, and ergonomic design is influencing both product development and procurement criteria. As a result, companies that align product roadmaps with software-driven workflows, interoperability standards, and flexible commercial models are best positioned to capitalize on these transformative shifts.

Assessing how recent tariff shifts have reshaped supply chains, procurement decisions, and manufacturing strategies across the diagnostic imaging equipment value chain

The implementation of tariffs by the United States in 2025 introduced a new layer of complexity to global diagnostic imaging supply chains and procurement strategies. Manufacturers that relied on cross-border sourcing for precision components and semiconductor-dependent subsystems faced increased input costs and longer lead times, prompting rapid reassessment of supplier concentration risks. In response, many organizations accelerated efforts to diversify suppliers, nearshore production of critical subassemblies, and redesign products to reduce dependence on tariff-impacted parts.

Healthcare providers and equipment distributors experienced pressure to renegotiate purchase terms and service agreements, as cost pressures were often transferred through the supply chain. Capital expenditure committees became more sensitive to total lifecycle cost implications and to the balance between immediate capital outlay and long-term service commitments. At the same time, some vendors pursued vertical integration and strategic partnerships to secure critical inputs and stabilize pricing. Regulatory compliance and customs-related administrative burdens also increased, raising the importance of trade expertise in procurement and contracting. Overall, the tariff environment catalyzed supply chain resilience initiatives, reshaping vendor relationships and accelerating manufacturing localization strategies that will influence procurement negotiation dynamics and product roadmaps in the medium term.

Distinctive segmentation-driven perspectives on modality differentiation, portability trade-offs, clinical application priorities, and end-user procurement behaviors influencing strategic positioning

Interpreting segmentation insights across product type, portability, application, and end-user dimensions provides clarity on where clinical needs and commercial opportunity intersect. Within product categories, computed tomography systems continue to evolve with distinctions between high-slice, mid-slice, and low-slice systems shaping use cases from advanced cross-sectional vascular studies to routine emergency diagnostics. Magnetic resonance imaging equipment remains divided between closed systems optimized for higher field strengths and open systems that prioritize patient comfort and interventional access. Nuclear imaging splits across PET and SPECT modalities, with PET maintaining strength in molecular oncology and SPECT serving broader cardiology and functional imaging indications. Ultrasound retains broad clinical utility with 2D imaging for general diagnostics, 3D and 4D platforms advancing obstetrical and fetal visualization, and Doppler systems enhancing vascular and cardiac flow assessment. X-ray systems continue their transition from analog platforms to digital radiography, improving image workflow and integration with PACS and reporting systems.

Portability defines a separate axis of differentiation, where fixed imaging equipment supports high-throughput centralized services while portable imaging equipment, spanning handheld devices and transportable units, enables decentralized diagnostics and rapid response in emergency or remote settings. Application-driven segmentation reveals modality adoption aligned to clinical domains: cardiology leverages coronary and vascular imaging for interventional planning and follow-up, neurology applies brain and spinal cord imaging for stroke and degenerative disease management, obstetrics and gynecology emphasize fetal monitoring and pelvic imaging, oncology requires early detection and staging plus ongoing monitoring, and orthopedics depends on fracture detection and joint-focused examinations. End-user segmentation likewise informs procurement cadence and service expectations; ambulatory care centers prioritize cost-effective, rapid turnaround systems, diagnostic imaging centers focus on specialized throughput and modality mix, and hospitals and clinics demand versatile, integrated platforms capable of supporting a wide range of acute and elective procedures. Understanding these segment intersections is critical for product positioning, capital planning, and clinical engagement strategies, as modality choice and configuration directly influence clinical workflow, staffing, and downstream revenue generation.

How regional healthcare infrastructure, regulatory fragmentation, and investment priorities are directing differential adoption and commercial strategies across global markets

Regional dynamics exert significant influence on adoption curves, regulatory approaches, and innovation diffusion across the diagnostic imaging industry. In the Americas, established healthcare infrastructure, consolidated vendor footprints, and advanced reimbursement frameworks support rapid uptake of high-end modalities and integrated software solutions, while systems procurement is often tied to demonstrated clinical outcomes and vendor service quality. In Europe, the Middle East & Africa, regulatory fragmentation and heterogeneous reimbursement environments create a patchwork of adoption, where advanced therapies and high-end devices perform strongly in developed pockets while other markets emphasize cost-effective, robust solutions. Policy shifts and centralized purchasing in some jurisdictions further influence pricing and tendering behaviors. In the Asia-Pacific region, investment in healthcare infrastructure, rising clinical demand, and favorable public health initiatives are driving accelerated adoption of both high-end modalities and portable imaging solutions, with several markets showing particular appetite for localized manufacturing partnerships and value-aligned service offerings.

Cross-region supply chain considerations, clinical training availability, and variations in patient demographics all shape how device lifecycles, service models, and aftermarket support are structured. Vendors and providers operating across regions must therefore calibrate product portfolios, financing options, and clinical education programs to local reimbursement realities and infrastructure constraints. Strategic regional partnerships and adaptable go-to-market models are essential to translate global innovation into sustainable regional adoption and to mitigate risks associated with regulatory changes and trade disruptions.

An incisive view of how incumbent manufacturers, nimble innovators, and software disruptors are shaping competitive dynamics through partnerships, services, and modular product strategies

The competitive landscape in diagnostic imaging is characterized by a mix of established multinational manufacturers, specialized niche innovators, and a growing cohort of software-first entrants focused on analytics and workflow optimization. Incumbent device manufacturers continue to emphasize integrated hardware-software bundles, lifecycle service agreements, and financing solutions that reduce adoption friction for large providers. Simultaneously, smaller firms and startups are carving out differentiation through focused clinical applications, disruptive form factors such as handheld ultrasound, and advanced image processing algorithms that can be deployed as cloud-enabled services.

Strategic partnerships, co-development agreements, and targeted acquisitions have emerged as primary levers for both scale and innovation. Many companies are investing in modular architectures that allow incremental feature upgrades, thereby extending product lifespans and creating recurring revenue through software subscriptions and clinical decision support tools. Aftermarket services and managed equipment programs are gaining prominence as revenue-stable offerings that align vendor incentives with provider uptime and performance. As competition intensifies, market leaders are balancing capital-intensive R&D with go-to-market investments in clinical validation, training programs, and customer success teams to accelerate adoption and capture downstream service revenue.

Practical and prioritized strategic actions that vendors and providers should implement to innovate, de-risk supply chains, and align commercial models with clinical outcomes

Industry leaders should adopt a multi-faceted strategy that balances innovation with supply chain resilience and customer-centric commercial models. Prioritizing investments in software and analytics can create differentiated clinical value while enabling recurring revenue through subscription services. At the same time, diversifying supplier bases and evaluating nearshoring or regional manufacturing partnerships will mitigate exposure to trade disruptions and input-cost volatility. Leaders should also reconsider traditional sales approaches by offering configurable financing, outcome-linked contracts, and comprehensive managed-service packages that align incentives with provider performance goals.

Operationally, building strong clinical validation programs and clinician-focused training will accelerate technology adoption and build long-term loyalty. Vendor teams should invest in interoperability and open-architecture designs to ease integration into heterogeneous hospital ecosystems and to support multi-vendor workflows. Finally, companies must integrate sustainability and dose-optimization features into product roadmaps as procurement committees increasingly weigh environmental and patient-safety credentials. By combining technical innovation with flexible commercial models and resilient operations, industry leaders can capture strategic growth while delivering measurable clinical and financial value to customers.

A robust mixed-methods research approach combining stakeholder interviews, clinical literature analysis, and scenario validation to ensure reliable and actionable insights

The research underpinning these insights blended qualitative and quantitative rigor through a structured methodology designed to triangulate evidence and ensure reproducibility. Primary research included structured interviews with clinicians, procurement officers, biomedical engineers, and industry executives, providing frontline perspectives on modality utilization, maintenance cycles, and purchase decision criteria. Secondary research encompassed peer-reviewed clinical studies, regulatory guidance documents, manufacturer technical specifications, and publicly available financial disclosures, which together informed assessments of technology readiness, clinical utility, and operational constraints.

Data synthesis employed cross-validation techniques to reconcile divergent views and to identify consensus trends. Case studies and real-world implementations were analyzed to extract lessons on deployment barriers and success factors. The methodology also incorporated scenario analysis to stress-test strategic assumptions under differing regulatory and supply chain conditions. Limitations were acknowledged, including variations in local reimbursement practices and the dynamic nature of software-driven innovation, and these were addressed through continuous stakeholder engagement and iterative validation cycles to maintain relevance and accuracy.

A concise synthesis of the converging technological, operational, and policy forces that will determine competitive success and clinical impact in diagnostic imaging

In synthesis, the diagnostic imaging equipment sector is at an inflection point where technological advances, shifting care delivery models, and supply chain realities are jointly redefining value creation. Innovations in software, image analytics, and portable hardware are unlocking new clinical use cases and enabling decentralized care workflows, while procurement strategies are increasingly guided by total cost of ownership, clinical outcome linkage, and service continuity. Trade policy and tariff changes have underscored the importance of supply chain diversification and have accelerated regional manufacturing conversations, adding a strategic layer to procurement and product design decisions.

Organizations that successfully integrate product innovation with resilient operations, flexible commercial frameworks, and clinician-centered implementation plans will gain competitive advantage. Moreover, the ability to validate clinical impact, ensure regulatory compliance across jurisdictions, and provide reliable aftermarket services will determine long-term vendor-provider relationships. As the sector continues to evolve, stakeholders should maintain agility in portfolio planning and prioritize investments that deliver demonstrable clinical benefit and operational efficiency across diverse care settings.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of AI-driven image analysis software in diagnostic imaging workflows to improve accuracy and efficiency
  • 5.2. Rapid adoption of photon-counting CT scanners for enhanced spatial resolution and reduced radiation dose
  • 5.3. Development of portable and handheld ultrasound devices enabling point-of-care diagnostics in remote settings
  • 5.4. Increasing deployment of hybrid PET/MRI systems for simultaneous metabolic and structural imaging in oncology
  • 5.5. Expansion of cloud-based PACS solutions with secure data sharing and AI-powered diagnostic support tools

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Diagnostic Imaging Equipment Market, by Product Type

  • 8.1. Computed Tomography (CT) Scanners
    • 8.1.1. High-Slice CT Scanners
    • 8.1.2. Low-Slice CT Scanners
    • 8.1.3. Mid-Slice CT Scanners
  • 8.2. Magnetic Resonance Imaging (MRI) Equipment
    • 8.2.1. Closed MRI Systems
    • 8.2.2. Open MRI Systems
  • 8.3. Nuclear Imaging Equipment
    • 8.3.1. PET Systems
    • 8.3.2. SPECT Systems
  • 8.4. Ultrasound Systems
    • 8.4.1. 2D Ultrasound Systems
    • 8.4.2. 3D & 4D Ultrasound Systems
    • 8.4.3. Doppler Ultrasound Systems
  • 8.5. X-Ray Systems
    • 8.5.1. Analog X-Ray Systems
    • 8.5.2. Digital X-Ray Systems

9. Diagnostic Imaging Equipment Market, by Portability

  • 9.1. Fixed Imaging Equipment
  • 9.2. Portable Imaging Equipment
    • 9.2.1. Handheld Portable Devices
    • 9.2.2. Transportable Equipment

10. Diagnostic Imaging Equipment Market, by Application

  • 10.1. Cardiology
    • 10.1.1. Coronary Imaging
    • 10.1.2. Vascular Imaging
  • 10.2. Neurology
    • 10.2.1. Brain Scans
    • 10.2.2. Spinal Cord Imaging
  • 10.3. Obstetrics & Gynecology
    • 10.3.1. Fetal Monitoring
    • 10.3.2. Pelvic Imaging
  • 10.4. Oncology
    • 10.4.1. Early Detection
    • 10.4.2. Staging & Monitoring
  • 10.5. Orthopedics
    • 10.5.1. Fracture Detection
    • 10.5.2. Joint Examination

11. Diagnostic Imaging Equipment Market, by End-User

  • 11.1. Ambulatory Care Centers
  • 11.2. Diagnostic Imaging Centers
  • 11.3. Hospitals & Clinics

12. Diagnostic Imaging Equipment Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Diagnostic Imaging Equipment Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Diagnostic Imaging Equipment Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Agfa-Gevaert Group
    • 15.3.2. Analogic Corporation
    • 15.3.3. Avonix Imaging, LLC by Nikon Corporation
    • 15.3.4. Barco NV
    • 15.3.5. Bracco S.p.A.
    • 15.3.6. Canon Medical Systems Corporation
    • 15.3.7. Carestream Health, Inc.
    • 15.3.8. Esaote S.p.A
    • 15.3.9. FUJIFILM Holdings Corporation
    • 15.3.10. GE HealthCare Technologies Inc.
    • 15.3.11. Hologic, Inc.
    • 15.3.12. Konica Minolta, Inc.
    • 15.3.13. Koninklijke Philips N.V.
    • 15.3.14. Medtronic PLC
    • 15.3.15. MinFound Medical Systems Co., Ltd.
    • 15.3.16. Neusoft Corporation
    • 15.3.17. Planmed Oy
    • 15.3.18. Samsung Electronics Co., Ltd
    • 15.3.19. Shanghai United Imaging Healthcare Co., Ltd.
    • 15.3.20. Shenzhen Mindray Bio-Medical Electronics Co Ltd
    • 15.3.21. Shenzhen SONTU Medical Imaging Equipment Co., Ltd.
    • 15.3.22. Shimadzu Corporation
    • 15.3.23. Siemens Healthineers
    • 15.3.24. Stryker Corporation
    • 15.3.25. Ziehm Imaging GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. DIAGNOSTIC IMAGING EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. DIAGNOSTIC IMAGING EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. DIAGNOSTIC IMAGING EQUIPMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HIGH-SLICE CT SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HIGH-SLICE CT SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HIGH-SLICE CT SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HIGH-SLICE CT SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HIGH-SLICE CT SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HIGH-SLICE CT SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY LOW-SLICE CT SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY LOW-SLICE CT SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY LOW-SLICE CT SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY LOW-SLICE CT SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY LOW-SLICE CT SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY LOW-SLICE CT SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MID-SLICE CT SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MID-SLICE CT SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MID-SLICE CT SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MID-SLICE CT SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MID-SLICE CT SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MID-SLICE CT SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CLOSED MRI SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CLOSED MRI SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CLOSED MRI SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CLOSED MRI SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CLOSED MRI SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CLOSED MRI SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OPEN MRI SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OPEN MRI SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OPEN MRI SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OPEN MRI SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OPEN MRI SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OPEN MRI SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PET SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PET SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PET SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PET SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PET SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PET SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPECT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPECT SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPECT SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPECT SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPECT SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPECT SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 2D ULTRASOUND SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 2D ULTRASOUND SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 2D ULTRASOUND SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 2D ULTRASOUND SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 2D ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 2D ULTRASOUND SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 3D & 4D ULTRASOUND SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 3D & 4D ULTRASOUND SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 3D & 4D ULTRASOUND SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 3D & 4D ULTRASOUND SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 3D & 4D ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY 3D & 4D ULTRASOUND SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DOPPLER ULTRASOUND SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DOPPLER ULTRASOUND SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DOPPLER ULTRASOUND SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DOPPLER ULTRASOUND SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DOPPLER ULTRASOUND SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DOPPLER ULTRASOUND SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY X-RAY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ANALOG X-RAY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ANALOG X-RAY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ANALOG X-RAY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ANALOG X-RAY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ANALOG X-RAY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ANALOG X-RAY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIGITAL X-RAY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIGITAL X-RAY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIGITAL X-RAY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIGITAL X-RAY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIGITAL X-RAY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIGITAL X-RAY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABILITY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FIXED IMAGING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FIXED IMAGING EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FIXED IMAGING EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FIXED IMAGING EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FIXED IMAGING EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FIXED IMAGING EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PORTABLE IMAGING EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HANDHELD PORTABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HANDHELD PORTABLE DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HANDHELD PORTABLE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HANDHELD PORTABLE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HANDHELD PORTABLE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HANDHELD PORTABLE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY TRANSPORTABLE EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY TRANSPORTABLE EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY TRANSPORTABLE EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY TRANSPORTABLE EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY TRANSPORTABLE EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY TRANSPORTABLE EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CORONARY IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CORONARY IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CORONARY IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CORONARY IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CORONARY IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY CORONARY IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY VASCULAR IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY BRAIN SCANS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY BRAIN SCANS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY BRAIN SCANS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY BRAIN SCANS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY BRAIN SCANS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY BRAIN SCANS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPINAL CORD IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPINAL CORD IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPINAL CORD IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPINAL CORD IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPINAL CORD IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SPINAL CORD IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FETAL MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FETAL MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FETAL MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FETAL MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FETAL MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FETAL MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PELVIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PELVIC IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PELVIC IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PELVIC IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PELVIC IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PELVIC IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY EARLY DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY EARLY DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY EARLY DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY EARLY DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY EARLY DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY EARLY DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY STAGING & MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY STAGING & MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY STAGING & MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY STAGING & MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY STAGING & MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY STAGING & MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ORTHOPEDICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FRACTURE DETECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FRACTURE DETECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FRACTURE DETECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FRACTURE DETECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FRACTURE DETECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY FRACTURE DETECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY JOINT EXAMINATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY JOINT EXAMINATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY JOINT EXAMINATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY JOINT EXAMINATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY JOINT EXAMINATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY JOINT EXAMINATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY COMPUTED TOMOGRAPHY (CT) SCANNERS, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY MAGNETIC RESONANCE IMAGING (MRI) EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY NUCLEAR IMAGING EQUIPMENT, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS DIAGNOSTIC IMAGING EQUIPMENT MARKET SIZE, BY ULTRASOUND SYSTEMS, 2018-2024 (USD MILLION)

TABLE